Boehringer Ingelheim and Eli Lilly and Company Alliance

Two companies. One commitment to diabetes. Boehringer Ingelheim and Eli Lilly and Company are working together, combining resources and focusing research and development to make a difference to those whose lives are impacted by diabetes. By partnering with the medical and healthcare community, together we are developing and bringing to market a broad range of new therapies to help improve patient outcomes in type 1 and type 2 diabetes. Boehringer Ingelheim and Eli Lilly and Company, two companies with one commitment to diabetes. 

Show On Map